A biochemical feedback signal for hypothermia treatment for neonatal hypoxic-ischemic encephalopathy: focusing on central nervous system proteins in biofluids

Hypothermia has been widely used to treat moderate to severe neonatal hypoxic-ischemic encephalopathy (HIE), yet evaluating the effects of hypothermia relies on clinical neurology, neuroimaging, amplitude-integrated electroencephalography, and follow-up data on patient outcomes. Biomarkers of brain...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongyan Lv (Author), Qiuli Wang (Author), Fang Liu (Author), Linhong Jin (Author), Pengshun Ren (Author), Lianxiang Li (Author)
Format: Book
Published: Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_54d68ab3d5f04e06b432946f5cc4e9e7
042 |a dc 
100 1 0 |a Hongyan Lv  |e author 
700 1 0 |a Hongyan Lv  |e author 
700 1 0 |a Qiuli Wang  |e author 
700 1 0 |a Fang Liu  |e author 
700 1 0 |a Linhong Jin  |e author 
700 1 0 |a Pengshun Ren  |e author 
700 1 0 |a Lianxiang Li  |e author 
245 0 0 |a A biochemical feedback signal for hypothermia treatment for neonatal hypoxic-ischemic encephalopathy: focusing on central nervous system proteins in biofluids 
260 |b Frontiers Media S.A.,   |c 2024-05-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2024.1288853 
520 |a Hypothermia has been widely used to treat moderate to severe neonatal hypoxic-ischemic encephalopathy (HIE), yet evaluating the effects of hypothermia relies on clinical neurology, neuroimaging, amplitude-integrated electroencephalography, and follow-up data on patient outcomes. Biomarkers of brain injury have been considered for estimating the effects of hypothermia. Proteins specific to the central nervous system (CNS) are components of nervous tissue, and once the CNS is damaged, these proteins are released into biofluids (cerebrospinal fluid, blood, urine, tears, saliva), and they can be used as markers of brain damage. Clinical reports have shown that CNS-specific marker proteins (CNSPs) were early expressed in biofluids after brain damage and formed unique biochemical profiles. As a result, these markers may serve as an indicator for screening brain injury in infants, monitoring disease progression, identifying damage region of brain, and assessing the efficacy of neuroprotective measures. In clinical work, we have found that there are few reports on using CNSPs as biological signals in hypothermia for neonatal HIE. The aim of this article is to review the classification, origin, biochemical composition, and physiological function of CNSPs with changes in their expression levels after hypothermia for neonatal HIE. Hopefully, this review will improve the awareness of CNSPs among pediatricians, and encourage future studies exploring the mechanisms behind the effects of hypothermia on these CNSPs, in order to reduce the adverse outcome of neonatal HIE. 
546 |a EN 
690 |a hypothermia 
690 |a neonatal hypoxic-ischemic encephalopathy 
690 |a central nervous system-specific proteins 
690 |a biomarker 
690 |a biochemical signals 
690 |a tau protein 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 12 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fped.2024.1288853/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/54d68ab3d5f04e06b432946f5cc4e9e7  |z Connect to this object online.